Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-010383-42Phase 4Completed
Phase 4 trial of remifentanil in esophagogastroduodenoscopy (2 arms), sponsored by IRCCS Ospedale San Raffaele. Primary endpoint: Patient satisfaction. Started Mar 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-010383-42.